Focus Partners Wealth
PRCT icon

Focus Partners Wealth’s Procept Biorobotics PRCT Stock Holding History

Focus Partners Wealth’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,931
Closed -$624K – 2926
2026
Q1 		$624K Sell
24,931
-168
-0.7% -$4.73K ﹤0.01% 1820
2025
Q4 		$790K Sell
25,099
-401
-2% -$13.3K ﹤0.01% 1738
2025
Q3 		$910K Buy
+25,500
New +$1.16M ﹤0.01% 1325
2025
Q2 		– Sell
-23,247
Closed -$1.35M – 2112
2025
Q1 		$1.35M Buy
23,247
+69
+0.3% +$4.71K ﹤0.01% 964
2024
Q4 		$1.87M Buy
23,178
+77
+0.3% +$6.58K ﹤0.01% 849
2024
Q3 		$1.84M Buy
+23,101
New +$1.64M 0.01% 782

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Focus Partners Wealth's PRCT Position: Q2 2026 in Review

Focus Partners Wealth sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 24,931 shares — an estimated $624K sold.

Focus Partners Wealth first reported a position in PRCT in Q3 2024 and held it in 6 quarters. The position peaked at $1.87M in Q4 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Focus Partners Wealth reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 24,931 Procept Biorobotics shares in Q2 2026, an estimated $624K.
  • Focus Partners Wealth first reported a position in Procept Biorobotics in Q3 2024 and held it in 6 quarters.
  • Focus Partners Wealth's Procept Biorobotics position peaked at $1.87M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.